Hon. Jared Moskowitz, a member of the U.S. House of Representatives, disclosed the sale of shares in STERIS plc (STE) under the STOCK Act’s periodic transaction reporting requirements. The transaction, executed by Moskowitz himself, was dated July 13, 2026, and falls within the $1,001 to $15,000 disclosure range. The holding was reported through Morgan Stanley Active Assets (1), a brokerage account structure commonly used by members of Congress to manage personal investments while in office.
The filing is classified on whoisbuyingnow.com as a congress sale, part of our ongoing effort to track how federal lawmakers report their personal trading activity under the transparency rules Congress imposed on itself. STOCK Act disclosures like this one are legally mandated and do not, on their own, suggest any wrongdoing. They simply give the public a window into the personal financial moves of elected officials, timed and amount-ranged rather than dollar-precise.
A Notable Cross-Signal at STERIS
What makes this filing worth flagging is its proximity to activity elsewhere at STERIS. Company insider Sohi Mohsen also sold STE shares, in a transaction dated August 12, 2026, valued at $349,921. That sale came within 30 days of Moskowitz’s disclosed transaction date, placing both moves in a similar window even though the dollar amounts and the nature of the sellers are entirely different. One is a congressional disclosure covering a modest dollar range; the other is a corporate insider sale of a much larger scale reported separately under SEC insider-trading rules.
We flag this kind of overlap not to suggest coordination or any improper connection, but because tracking clusters of activity around the same ticker, whether from lawmakers, corporate insiders, or institutional managers, is exactly the kind of pattern our readers come to whoisbuyingnow.com to see. A sale by a member of Congress and a sale by a company insider happening close together in time is a data point worth logging, nothing more.
Readers interested in how professional money managers approach positions like this from an institutional angle may want to review our coverage of Defilade Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly, which tracks quarterly filings from a separate class of market participants.
As always, this report reflects only the facts disclosed in the public filing and the referenced insider transaction. Amount ranges reported under the STOCK Act are estimates set by law, not exact figures, and the timing of a disclosure does not necessarily reflect the timing of any related decision-making. We will continue monitoring STE-related filings from both Congress and company insiders as they become available.